InvestorLens

DHR — DANAHER CORPORATION

Health Care · Diagnostics & Research

Sign in to save6 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying DHR?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
80
Institutional Conviction
Net accumulation · 4 buying vs 1 selling last quarter
62
Macro Tailwind
Macro conditions are mixed for this sector
53
Congressional Activity
1 congressional purchase, 0 sales disclosed in the last 6 months
Why? — Evidence & Confidence ▾

Of 5 tracked investors who changed their DHR position last quarter, 4 bought and 1 sold (80% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime). 1 congressional purchase, 0 sales disclosed in the last 6 months.

Supporting evidence
  • +4 tracked investors added or increased positions last quarter (Chase Coleman, Stanley Druckenmiller, Daniel Loeb, …)
  • +6 tracked investors reported holding DHR at their latest filing
Contradicting evidence — always shown
  • −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About DANAHER CORPORATION (DHR)

DANAHER CORPORATION (DHR) appears in the most recent 13F filings of 6 tracked institutional investors. DANAHER CORPORATION is classified in the Health Care sector (Diagnostics & Research industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $821M. Across recent filings, tracked investors recorded 13 new positions, 12 increased, 17 reduced, and 7 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in DHR

51
/100
Mixed Activity
Added / Increased25
Reduced17
Exited7
BearishBullish
Crowded Trade Score™

How many top investors track DHR

40
/100
Moderate Interest
6investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

DHR Ownership Composition

How DANAHER CORPORATION is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
81% of tracked value
Institutions
6
tracked investors
Total Reported
$1B
combined 13F value
Types4
  • Multi-Strategy / Quant80.5%
  • Activist9.8%
  • Growth & Innovation8.3%
  • Macro1.4%
Multi-Strategy / Quant(2)
80.5%
Activist(1)
9.8%
Growth & Innovation(1)
8.3%
Macro(2)
1.4%

Tracked investors currently reporting DHR

5 tracked investors have since exited this position — listed separately below.

  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    1.9M
    Value
    $371.1M
    % Portfolio
    0.04%
  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    2.5M
    Value
    $473.5M
    % Portfolio
    0.17%
  • Daniel LoebJun 30, 2026
    Third Point LLC
    Shares
    540K
    Value
    $102.9M
    % Portfolio
    2.20%
  • Chase ColemanJun 30, 2026
    Tiger Global Management
    Shares
    456K
    Value
    $86.9M
    % Portfolio
    0.36%
  • Stanley DruckenmillerJun 30, 2026
    Duquesne Family Office
    Shares
    50.3K
    Value
    $9.6M
    % Portfolio
    0.18%
  • Ray DalioJun 30, 2026
    Bridgewater Associates
    Shares
    25.7K
    Value
    $4.9M
    % Portfolio
    0.02%

Previously held DHR

These investors reported DHR in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management1.2M$231.9MMar 31, 2026
Andreas HalvorsenViking Global Investors2.8M$545.5MSep 30, 2025
Philippe LaffontCoatue Management334.1K$83.4MMar 31, 2024
Paul Tudor JonesTudor Investment Corp319.6K$63.4MSep 30, 2025
George SorosSoros Fund Management40K$8.2MMar 31, 2025

Recent activity

Frequently asked questions

How many institutional investors hold DHR?
6 tracked institutional investors disclosed a position in DHR (DANAHER CORPORATION) in their most recent 13F filing.
Who is the largest institutional holder of DHR?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in DHR, valued at $821M.
Did institutional ownership of DHR increase or decrease?
Across recent 13F filings, tracked investors recorded 13 new positions, 12 increased, 17 reduced, and 7 fully exited DHR.
What sector is DHR in?
DANAHER CORPORATION is classified in the Health Care GICS sector, Diagnostics & Research industry.
Where does this DHR ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.